Cannell & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $9.43M | Sell |
10,742
-175
| -2% | -$154K | 0.3% | 77 |
|
|
2023
Q3 | $8.98M | Sell |
10,917
-10
| -0.1% | -$8.23K | 0.31% | 81 |
|
|
2023
Q2 | $7.85M | Buy |
10,927
+80
| +0.7% | +$57.5K | 0.26% | 92 |
|
|
2023
Q1 | $8.91M | Sell |
10,847
-1,431
| -12% | -$1.18M | 0.32% | 84 |
|
|
2022
Q4 | $8.86M | Buy |
12,278
+23
| +0.2% | +$16.6K | 0.32% | 82 |
|
|
2022
Q3 | $8.44M | Sell |
12,255
-33
| -0.3% | -$22.7K | 0.32% | 81 |
|
|
2022
Q2 | $7.26M | Sell |
12,288
-202
| -2% | -$119K | 0.26% | 91 |
|
|
2022
Q1 | $8.72M | Sell |
12,490
-65
| -0.5% | -$45.4K | 0.26% | 94 |
|
|
2021
Q4 | $7.93M | Sell |
12,555
-535
| -4% | -$338K | 0.22% | 98 |
|
|
2021
Q3 | $7.92M | Buy |
13,090
+89
| +0.7% | +$53.9K | 0.24% | 98 |
|
|
2021
Q2 | $7.26M | Sell |
13,001
-5
| -0% | -$2.79K | 0.22% | 101 |
|
|
2021
Q1 | $6.15M | Sell |
13,006
-9,700
| -43% | -$4.59M | 0.19% | 108 |
|
|
2020
Q4 | $11M | Buy |
22,706
+9,461
| +71% | +$4.57M | 0.36% | 76 |
|
|
2020
Q3 | $7.41M | Buy |
13,245
+299
| +2% | +$167K | 0.27% | 86 |
|
|
2020
Q2 | $8.07M | Sell |
12,946
-22,276
| -63% | -$13.9M | 0.32% | 72 |
|
|
2020
Q1 | $17.2M | Sell |
35,222
-431
| -1% | -$210K | 0.83% | 40 |
|
|
2019
Q4 | $13.7M | Buy |
35,653
+23,857
| +202% | +$9.2M | 0.49% | 69 |
|
|
2019
Q3 | $3.27M | Sell |
11,796
-4,985
| -30% | -$1.38M | 0.12% | 118 |
|
|
2019
Q2 | $5.25M | Sell |
16,781
-21,177
| -56% | -$6.63M | 0.2% | 102 |
|
|
2019
Q1 | $15.6M | Sell |
37,958
-6,869
| -15% | -$2.82M | 0.6% | 62 |
|
|
2018
Q4 | $16.7M | Sell |
44,827
-1,036
| -2% | -$387K | 0.73% | 47 |
|
|
2018
Q3 | $18.5M | Buy |
45,863
+13,147
| +40% | +$5.31M | 0.66% | 54 |
|
|
2018
Q2 | $11.3M | Buy |
32,716
+31,736
| +3,238% | +$10.9M | 0.42% | 69 |
|
|
2018
Q1 | $337K | Buy |
+980
| New | +$337K | 0.01% | 213 |
|